Finally, many people report feeling an improvement to energy levels, performance, and greater mental clarity

CrossRef The GutLiver Axis in Metabolic DysfunctionAssociated Steatotic Liver Disease: From Mechanistic Insights to Precision Therapeutics Shaoliang Zhu, Mengjie Zou, Qijun Wu, Yan Zou, Tingting Tan, Zhangnan Huang, Zheng Gong, Honglin Luo, Xiaofeng Dong The FASEB Journal .2026;[Epub] CrossRef Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes Konstantinos Malandris, Konstantinos Charalampidis, Rohit Loomba, Emmanouil Sinakos Current Diabetes Reports .2026;[Epub] CrossRef Association between weekend catch-up sleep and Metabolic dysfunction-associated steatotic liver disease in US adults Jinlong Chen, Wei Wang, Jie He, Xinxin Fang Clinical and Experimental Medicine .2026;[Epub] CrossRef Ginsenoside Rg1 alleviates MASH by targeting GLS2 to enhance PINK1/Parkin-mediated mitophagy and improve mitochondrial function Zhijian Wang, Yinuo Wang, Peiyun Peng, Huating Luo, Liuling Xiao, Wenxiang Huang Biochemical Pharmacology .2026

By age 65, that reduction can reach 50 percent
In this context, there is an emphasis on the need for a deeper understanding of the functions of FOXO in the nervous system, which could lead to the development of targeted research approaches for these severe diseases
These mechanisms are powerful